| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Can-Fite BioPharma Ltd (TA: CANF)
CANF Technical Analysis
5
| As on 9th Jan 2026 CANF STOCK Price closed @ 678.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.51 & Strong Buy for SHORT-TERM with Stoploss of 1.97 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CANFSTOCK Price
| Open | 700.00 | Change | Price | % |
| High | 700.00 | 1 Day | 677.00 | 67700.00 |
| Low | 670.20 | 1 Week | 677.00 | 67700.00 |
| Close | 678.00 | 1 Month | 677.00 | 67700.00 |
| Volume | 3700 | 1 Year | 675.30 | 25011.11 |
| 52 Week High 678.00 | 52 Week Low 1.00 | ||||
TA Israel Most Active Stocks
| TA125 | 2008.05 | 1.06% |
| BONS | 43.90 | 6.55% |
| ORL | 106.90 | 2.89% |
| GNRS | 151.70 | 1.68% |
| POLI | 7672.00 | 2.20% |
| ARDM | 48.10 | 0.21% |
| APLY | 48.10 | 0.21% |
| TDGN-L | 171.50 | 17.55% |
| BEZQ | 725.00 | -0.62% |
| ICL | 1769.00 | 0.11% |
TA Israel Top Gainers Stocks
TA Israel Top Losers Stocks
| CANF Daily Charts |
CANF Intraday Charts |
Whats New @ Bazaartrend |
CANF Free Analysis |
|
|
CANF Important Levels Intraday
| RESISTANCE | 735.42 |
| RESISTANCE | 717.01 |
| RESISTANCE | 705.62 |
| RESISTANCE | 694.24 |
| SUPPORT | 661.76 |
| SUPPORT | 650.38 |
| SUPPORT | 638.99 |
| SUPPORT | 620.58 |
CANF Forecast January 2026
| 4th UP Forecast | 678.96 |
| 3rd UP Forecast | 678.65 |
| 2nd UP Forecast | 678.46 |
| 1st UP Forecast | 678.27 |
| 1st DOWN Forecast | 677.73 |
| 2nd DOWN Forecast | 677.54 |
| 3rd DOWN Forecast | 677.35 |
| 4th DOWN Forecast | 677.04 |
CANF Weekly Forecast
| 4th UP Forecast | 679.93 |
| 3rd UP Forecast | 679.31 |
| 2nd UP Forecast | 678.93 |
| 1st UP Forecast | 678.55 |
| 1st DOWN Forecast | 677.46 |
| 2nd DOWN Forecast | 677.07 |
| 3rd DOWN Forecast | 676.69 |
| 4th DOWN Forecast | 676.07 |
CANF Forecast2026
| 4th UP Forecast | 2024.97 |
| 3rd UP Forecast | 1592.99 |
| 2nd UP Forecast | 1325.97 |
| 1st UP Forecast | 1058.96 |
| 1st DOWN Forecast | 297.05 |
| 2nd DOWN Forecast | 30.03 |
| 3rd DOWN Forecast | -236.99 |
| 4th DOWN Forecast | -668.97 |
Can-Fite BioPharma Ltd ( TA Israel Symbol : CANF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CANF Business Profile
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, COVID-19 and erectile dysfunction. The company's lead drug candidate CF101 (Piclidenoson), which is in Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops CF102 (Namodenoson) that is completed Phase II clinical trial for the treatment of hepatocellular carcinoma, as well as in Phase II trial for the treatment of non-alcoholic steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, the company develops commercial predictive biomarker blood test kit for A3AR. Can-Fite BioPharma Ltd. has collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. The company was formerly known as Can-Fite Technologies Ltd. and changed its name to Can-Fite BioPharma Ltd. in January 2001. Can-Fite BioPharma Ltd. was incorporated in 1994 and is headquartered in Petah-Tikva, Israel. Address: 10 Bareket Street, Petah Tikva, Israel, 4951778
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service